This week on Fear & Greed Q&A, Michael puts Sean and Adam on the spot with five rapid-fire questions — no notice, no prep — all about airlines, loyalty programs, business class, and the little things that make flying either a joy… or deeply irritating.

With Qantas reporting record profits and the loyalty program battle with Virgin heating up, the trio unpack whether points actually influence booking decisions, whether airline loyalty is now the real business of aviation, and if business class is worth the splurge.

They also share their best-ever flight experiences (including a first-class surprise upgrade and a childhood trip that set the bar impossibly high), before a candid look at modern flight etiquette — from overhead locker offenders to mid-air commentators.

Find out more: https://fearandgreed.com.au/

See omnystudio.com/listener for privacy information.

Company results galore, an inflation surprise, and two of the best CEO performances of the past couple of years - all in one week.

Sean Aylmer and Michael Thompson go head to head on the top business stories of the week, with Adam Lang picking a winner in a fierce debate.

Join our free daily newsletter here.

Find out more: https://fearandgreed.com.au/

See omnystudio.com/listener for privacy information.

This is the Fear and Greed Afternoon Report - everything you need to know about what happened in the markets, economy and world of business today, in just a few minutes.

1. ASX hits record again

2. Coalition won’t release review

3. Last day of earnings season

4. ASIC v Budget Direct

5. Block slashes 40% of jobs

Join our free daily newsletter here.

Find out more: https://fearandgreed.com.au/

See omnystudio.com/listener for privacy information.

Friday 27 February 2026

Qantas unveils a record profit but a slowdown in its international business sends its share price tumbling.

• Global share markets, including the ASX, hit record levels
• Mobile phones set to blast a test emergency warning across the country
• The latest in the tax debate
• Donald Trump becomes further embroiled in the Epstein files

Join our free daily newsletter here.

And don’t miss the latest episode of How Do They Afford That? - this week, starting from scratch with money. Get the episode from APPLE, SPOTIFY, or anywhere you listen to podcasts.

Find out more: https://fearandgreed.com.au/

See omnystudio.com/listener for privacy information.

Last year Domain became part of Nasdaq-listed CoStar Group, a global leader in commercial real estate data and analytics. Domain President Jason Pellegrino joins Sean Aylmer to explain what that means for the Australian property platform and how being part of a much larger, data-driven international organisation changes the game.

They discuss why confidence is the core need of property buyers everywhere, how AI is reshaping the journey, and why commercial property in Australia is a “white space” ripe for disruption.

Domain is a supporter of Fear & Greed

Find out more: https://fearandgreed.com.au/

See omnystudio.com/listener for privacy information.

This is the Fear and Greed Afternoon Report - everything you need to know about what happened in the markets, economy and world of business today, in just a few minutes.

1. ASX hits another record

2. RBA Governor on inflation

3. Diplomat families told to leave Middle East

4. Results wrap

5. NVIDIA’s massive profit

Join our free daily newsletter here.

Find out more: https://fearandgreed.com.au/

See omnystudio.com/listener for privacy information.

Thursday 26 February 2026

Higher than expected inflation figures have upped the chance of an interest rate hike in coming months.

• The local sharemarket hits an all-time high
• A bumper profit at Woolworths sends its share price up the most in 30 years
• AI bites, with WiseTech Global to cut 2,000 jobs
• Donald Trump’s loud, abrasive State of the Union address

Join our free daily newsletter here.

And don’t miss the latest episode of How Do They Afford That? - this week, starting from scratch with money. Get the episode from APPLE, SPOTIFY, or anywhere you listen to podcasts.

Find out more: https://fearandgreed.com.au/

See omnystudio.com/listener for privacy information.

Biotech company Imugene reported its half-year results yesterday. It’s still loss-making, but sharply cutting costs and seeing what appear to be genuinely encouraging clinical results.

Its lead cancer therapy, azer-cel, is showing strong response rates in difficult lymphoma cases, with some patients cancer-free for nearly two years - and the FDA has given positive feedback on the company’s strategy.

But at the same time, the company’s share price is down around 80pc over the last year.

Sean Aylmer speaks to Leslie Chong, CEO and Managing Director of Imugene, about what it takes to run a long-cycle biotech business, trying to develop life-changing treatments while keeping investors engaged.

Find out more: https://fearandgreed.com.au/

See omnystudio.com/listener for privacy information.